KRAS and colorectal carcinoma: Similarly, circular RNAs were found to be downregulated in HCT116 and KRAS mutant cells compared to cells bearing wild type KRAS [157] suggesting its use as a biomarker in the screening of CRC patients bearing KRAS mutation.